\ua9 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.Objective: To determine the current practice in genetic testing for patients with apparently sporadic motor neurone disease/amyotrophic lateral sclerosis (MND/ALS) and asymptomatic at-risk relatives of familial MND/ALS patients seen in specialized care centers in the UK. Methods: An online survey with 10 questions distributed to specialist healthcare professionals with a role in requesting genetic testing working at MND/ALS care centers. Results: Considerable variation in practice was found. Almost 30% of respondents reported some discomfort in discussing genetic testing with MND/ALS patients and a majority (77%) did not think that all patients w...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
Objective: To determine the current practice in genetic testing for patients with apparently sporadi...
\ua9 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.Obje...
Background: Pathogenic variants in ALS genes are known to be present in up to 70% of familial and 10...
The clinical utility of routine genetic sequencing in amyotrophic lateral sclerosis is uncertain. Ou...
Amyotrophic lateral sclerosis (ALS) is a heterogeneous neurodegenerative syndrome. In up to 20% of c...
INTRODUCTION: Motor neuron disease (MND) and frontotemporal dementia (FTD) comprise a neurodegenerat...
INTRODUCTION: Motor neuron disease (MND) and frontotemporal dementia (FTD) comprise a neurodegenerat...
Objective: In 2021, the Clinical Genome Resource (ClinGen) amyotrophic lateral sclerosis (ALS) spect...
Objective: The clinical utility of routine genetic sequencing in amyotrophic lateral sclerosis (ALS)...
Several genetically-targeted therapies are being developed for ALS. Research is increasingly support...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
Objective: To determine the current practice in genetic testing for patients with apparently sporadi...
\ua9 2022 The Author(s). Published by Informa UK Limited, trading as Taylor & Francis Group.Obje...
Background: Pathogenic variants in ALS genes are known to be present in up to 70% of familial and 10...
The clinical utility of routine genetic sequencing in amyotrophic lateral sclerosis is uncertain. Ou...
Amyotrophic lateral sclerosis (ALS) is a heterogeneous neurodegenerative syndrome. In up to 20% of c...
INTRODUCTION: Motor neuron disease (MND) and frontotemporal dementia (FTD) comprise a neurodegenerat...
INTRODUCTION: Motor neuron disease (MND) and frontotemporal dementia (FTD) comprise a neurodegenerat...
Objective: In 2021, the Clinical Genome Resource (ClinGen) amyotrophic lateral sclerosis (ALS) spect...
Objective: The clinical utility of routine genetic sequencing in amyotrophic lateral sclerosis (ALS)...
Several genetically-targeted therapies are being developed for ALS. Research is increasingly support...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...
The clinical approach to patients with amyotrophic lateral sclerosis (ALS) has been largely modified...